Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.

Autor:	Luen, S J1 (AUTHOR), Salgado, R2 (AUTHOR), Dieci, M V3 (AUTHOR), Vingiani, A4 (AUTHOR), Curigliano, G5 (AUTHOR), Gould, R E6 (AUTHOR), Castaneda, C7 (AUTHOR), D'Alfonso, T8 (AUTHOR), Sanchez, J7 (AUTHOR), Cheng, E9 (AUTHOR), Andreopoulou, E9 (AUTHOR), Castillo, M7 (AUTHOR), Adams, S10 (AUTHOR), Demaria, S9 (AUTHOR), Symmans, W F6 (AUTHOR), Michiels, S11 (AUTHOR), Loi, S1 (AUTHOR) sherene.loi@petermac.org
Zdroj:	Annals of Oncology. Feb2019, Vol. 30 Issue 2, p236-242. 7p. 4 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu